Chemed Co. (NYSE:CHE) Shares Bought by Linden Thomas Advisory Services LLC

Linden Thomas Advisory Services LLC lifted its position in Chemed Co. (NYSE:CHE) by 0.8% in the 4th quarter, Holdings Channel.com reports. The fund owned 7,017 shares of the company’s stock after acquiring an additional 57 shares during the period. Chemed makes up 0.8% of Linden Thomas Advisory Services LLC’s investment portfolio, making the stock its 7th largest position. Linden Thomas Advisory Services LLC’s holdings in Chemed were worth $4,103,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in the company. Wealth Alliance grew its position in shares of Chemed by 3.0% in the 4th quarter. Wealth Alliance now owns 578 shares of the company’s stock worth $338,000 after acquiring an additional 17 shares in the last quarter. Fifth Third Bancorp lifted its holdings in shares of Chemed by 0.5% in the 3rd quarter. Fifth Third Bancorp now owns 3,914 shares of the company’s stock worth $2,034,000 after purchasing an additional 21 shares during the last quarter. Legacy Wealth Asset Management LLC lifted its holdings in shares of Chemed by 0.9% in the 4th quarter. Legacy Wealth Asset Management LLC now owns 2,275 shares of the company’s stock worth $1,330,000 after purchasing an additional 21 shares during the last quarter. Signaturefd LLC lifted its holdings in shares of Chemed by 5.8% in the 4th quarter. Signaturefd LLC now owns 385 shares of the company’s stock worth $225,000 after purchasing an additional 21 shares during the last quarter. Finally, Kestra Advisory Services LLC lifted its holdings in shares of Chemed by 3.8% in the 3rd quarter. Kestra Advisory Services LLC now owns 634 shares of the company’s stock worth $329,000 after purchasing an additional 23 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Stock Up 1.8 %

Chemed stock traded up $10.61 during mid-day trading on Tuesday, hitting $615.03. 58,309 shares of the company’s stock traded hands, compared to its average volume of 77,228. The firm has a 50 day moving average price of $622.33 and a 200 day moving average price of $589.76. The company has a market cap of $9.30 billion, a PE ratio of 33.74, a price-to-earnings-growth ratio of 2.41 and a beta of 0.42. Chemed Co. has a one year low of $492.84 and a one year high of $654.62.

Chemed (NYSE:CHE) last announced its earnings results on Tuesday, February 27th. The company reported $6.60 earnings per share for the quarter, beating the consensus estimate of $6.25 by $0.35. The firm had revenue of $585.90 million for the quarter, compared to the consensus estimate of $586.64 million. Chemed had a return on equity of 32.29% and a net margin of 12.03%. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.39 EPS. On average, analysts expect that Chemed Co. will post 21.99 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Monday, February 26th were paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.26%. The ex-dividend date was Friday, February 23rd. Chemed’s dividend payout ratio is presently 8.93%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CHE. Oppenheimer raised their price target on Chemed from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Thursday, February 29th. Royal Bank of Canada raised their price target on Chemed from $604.00 to $712.00 and gave the stock an “outperform” rating in a report on Monday, March 4th.

Insider Transactions at Chemed

In other news, VP Brian C. Judkins sold 11,158 shares of the business’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total value of $7,196,910.00. Following the sale, the vice president now owns 1,422 shares of the company’s stock, valued at approximately $917,190. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Spencer S. Lee sold 2,000 shares of Chemed stock in a transaction on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the transaction, the executive vice president now directly owns 20,760 shares in the company, valued at approximately $13,320,654. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Brian C. Judkins sold 11,158 shares of Chemed stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total value of $7,196,910.00. Following the completion of the transaction, the vice president now owns 1,422 shares in the company, valued at $917,190. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,808 shares of company stock valued at $10,184,531. Corporate insiders own 3.32% of the company’s stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.